Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 50Prostatic Neoplasms 44Multiple Myeloma 22Neoplasm Metastasis 17Osteoporosis 14Pain 11Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Neoplasms, Plasma Cell 5Lung Neoplasms 5Bone Diseases, Metabolic 5Fractures, Bone 4Bone Diseases 4Lymphoma 3Carcinoma, Renal Cell 3Bone Neoplasms 3Spinal Cord Compression 2Ovarian Neoplasms 2Osteosarcoma 2Neuroblastoma 2Kidney Neoplasms 2Humoral Hypercalcemia Of Malignancy 2Triple Negative Breast Neoplasms 1Treatment of Bone Metastases 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Sarcoma 1Renal Insufficiency 1Recurrence 1Pleural Effusion, Malignant 1

Interventions

Zoledronic Acid 2Radiotherapy 2Denosumab 2Radiosurgery 1Melphalan 1Infusions, Intra-Arterial 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Spinal Cord Compression × Zoledronic Acid × Clear all
NCT01345019 2022-11-08

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Amgen

Phase 3 Completed
1,718 enrolled 22 charts
Other hematologic neoplasmPlasma cellSarcoma

Blood Protein Disorders, Bone Diseases, Bone Marrow Diseases, Bone Neoplasms, Hematologic Diseases, Multiple Myeloma, Neoplasm Metastasis, Neoplasms, Neoplastic Processes, Paraproteinemias, Spinal Cord Compression, Hematologic Neoplasms, Fractures, Bone, Neoplasms, Plasma Cell

NCT00330759 2022-11-07

Study of Denosumab vs. Zoledronic Acid to Treat Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma.

Amgen

Phase 3 Completed
1,779 enrolled 14 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Spinal Cord Compression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡